E2F1 and cancer: Second, we measure the miR-185-3p transcriptional target, E2F1 mRNA, in a prospective multidisciplinary study, in relation to cancer subtypes, stage, and grade, in order to link obtained results with the clinicopathological features and the clinical outcome.